I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

DYN Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 20.77%

Insider Buying (Last 12 Months): $31,057,267.50

Insider Selling (Last 12 Months): $62,196,431.71

Dyne Therapeutics Insider Trading History Chart

Dyne Therapeutics Share Price & Price History

^$28.74

▼ -0.12 (-0.42%)

As of 11/1/2024 01:00 AM ET

Days: 30 | 90 | 365

625,000% Gain

From Crypto Swap Profits | Ad

Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.

>> Dive into the Workshop Here

Dyne Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
10/16/2024	Dirk Kersten	Director	Sell	23,671	$35.35	$836,769.85	99,652
9/25/2024	Dirk Kersten	Director	Sell	2,357	$35.06	$82,636.42	190,939
9/23/2024	Dirk Kersten	Director	Sell	40,831	$35.32	$1,442,150.92	193,296
9/20/2024	Dirk Kersten	Director	Sell	79,411	$36.45	$2,894,530.95	234,127
9/18/2024	Oxana Beskrovnaya	Insider	Sell	2,339	$34.55	$80,812.45	140,375
9/18/2024	Richard William Scalzo	SVP	Sell	1,390	$34.55	$48,024.50	98,568
9/18/2024	Susanna High	COO	Sell	8,976	$34.41	$308,864.16	131,636
9/4/2024	John Cox	CEO	Buy	32,000	$33.04	$1,057,280.00	8,000
6/24/2024	Susanna High	COO	Sell	10,163	$35.33	$359,058.79	148,792
6/21/2024	Susanna High	COO	Sell	29,787	$35.01	$1,042,842.87	148,792
6/12/2024	Susanna High	COO	Sell	40,000	$33.36	$1,334,400.00	148,792
6/11/2024	Oxana Beskrovnaya	Insider	Sell	2,136	$31.34	$66,942.24	147,511
6/10/2024	Richard William Scalzo	SVP	Sell	1,590	$30.23	$48,065.70	115,105
6/10/2024	Susanna High	COO	Sell	80,000	$30.24	$2,419,200.00	154,062
5/20/2024	Oxana Beskrovnaya	Insider	Sell	30,426	$32.96	$1,002,840.96	149,647
5/16/2024	Oxana Beskrovnaya	Insider	Sell	2,705	$28.27	$76,470.35	149,647
5/16/2024	Richard William Scalzo	SVP	Sell	2,588	$28.27	$73,162.76	116,695
5/16/2024	Susanna High	COO	Sell	2,738	$28.27	$77,403.26	154,062
3/11/2024	Joshua T Brumm	CEO	Sell	66,387	$25.67	$1,704,154.29	537,998
3/11/2024	Richard William Scalzo	SVP	Sell	2,672	$25.28	$67,548.16	119,283
3/11/2024	Susanna High	COO	Sell	2,292	$25.70	$58,904.40	156,800
3/11/2024	Wildon Farwell	Insider	Sell	1,585	$25.70	$40,734.50	151,590
3/7/2024	Joshua T Brumm	CEO	Sell	9,086	$25.85	$234,873.10	554,385
3/7/2024	Oxana Beskrovnaya	Insider	Sell	2,373	$25.85	$61,342.05	154,433
3/7/2024	Richard William Scalzo	SVP	Sell	2,273	$25.85	$58,757.05	121,955
3/7/2024	Susanna High	COO	Sell	1,591	$25.85	$41,127.35	186,291
2/29/2024	Jonathan Mcneill	Insider	Sell	4,268	$27.50	$117,370.00	143,618
2/29/2024	Joshua T Brumm	CEO	Sell	5,520	$27.50	$151,800.00	563,471
2/29/2024	Richard William Scalzo	SVP	Sell	3,429	$27.50	$94,297.50	124,228
2/28/2024	Jason P Rhodes	Director	Sell	190,920	$24.84	$4,742,452.80	864,487
2/28/2024	Venture Fund Xi L.P. Atlas	Major Shareholder	Sell	154,674	$24.84	$3,842,102.16	5,698,091
2/26/2024	Jason P Rhodes	Director	Sell	248,219	$23.72	$5,887,754.68	903,527
2/26/2024	Venture Fund Xi L.P. Atlas	Major Shareholder	Sell	201,095	$23.72	$4,769,973.40	6,151,467
2/23/2024	Venture Fund Xi L.P. Atlas	Major Shareholder	Sell	159,542	$22.70	$3,621,603.40	6,352,562
2/22/2024	Jason P Rhodes	Director	Sell	119,360	$22.66	$2,704,697.60	6,512,104
2/21/2024	Venture Fund Xi L.P. Atlas	Major Shareholder	Sell	184,501	$22.57	$4,164,187.57	6,631,464
2/20/2024	Jason P Rhodes	Director	Sell	169,539	$22.72	$3,851,926.08	6,815,965
2/16/2024	Venture Fund Xi L.P. Atlas	Major Shareholder	Sell	162,707	$23.14	$3,765,039.98	6,985,504
2/15/2024	Jason P Rhodes	Director	Sell	177,906	$23.89	$4,250,174.34	7,148,211
2/12/2024	Wildon Farwell	Insider	Sell	5,493	$25.07	$137,709.51	163,503
1/26/2024	Richard William Scalzo	SVP	Sell	13,000	$24.34	$316,420.00	124,228
1/26/2024	Wildon Farwell	Insider	Sell	100	$25.00	$2,500.00	168,996
1/9/2024	Dirk Kersten	Director	Buy	1,714,285	$17.50	$29,999,987.50	6,416,793
1/4/2024	Joshua T Brumm	CEO	Sell	218,536	$18.51	$4,045,101.36	584,971
1/3/2024	Oxana Beskrovnaya	Insider	Sell	45,326	$18.98	$860,287.48	176,585
1/3/2024	Richard William Scalzo	SVP	Sell	13,000	$18.81	$244,530.00	124,228
12/14/2023	Richard William Scalzo	Insider	Sell	2,376	$12.02	$28,559.52	124,228
12/11/2023	Richard William Scalzo	Insider	Sell	1,380	$10.72	$14,793.60	126,604
12/11/2023	Susanna High	COO	Sell	1,616	$10.72	$17,323.52	187,882
12/6/2023	Richard William Scalzo	Insider	Sell	1,872	$12.01	$22,482.72	127,984
12/4/2023	Richard William Scalzo	Insider	Sell	681	$12.01	$8,178.81	129,856
11/2/2023	Susanna High	COO	Sell	9,939	$7.40	$73,548.60	94,605
9/18/2023	Richard William Scalzo	Insider	Sell	1,290	$9.41	$12,138.90	40,795
9/18/2023	Susanna High	COO	Sell	2,672	$9.41	$25,143.52	104,544
9/12/2023	Susanna High	COO	Sell	1,635	$10.41	$17,020.35	107,216
9/12/2023	Wildon Farwell	Insider	Sell	1,707	$10.41	$17,769.87	89,250
6/15/2023	Richard William Scalzo	Insider	Sell	10,000	$12.03	$120,300.00	43,482
6/13/2023	Susanna High	COO	Sell	1,625	$12.43	$20,198.75	108,851
6/12/2023	Joshua T Brumm	Insider	Sell	187,748	$12.61	$2,367,502.28	253,383
6/9/2023	Joshua T Brumm	Insider	Sell	76,582	$13.34	$1,021,603.88	269,771
3/14/2023	Richard William Scalzo	Insider	Sell	1,311	$13.33	$17,475.63	54,872
3/14/2023	Susanna High	COO	Sell	1,559	$13.33	$20,781.47	110,476
1/18/2023	Jonathan Mcneill	Insider	Sell	10,000	$14.03	$140,300.00	67,600
1/9/2023	Jonathan Mcneill	Insider	Sell	30,150	$11.57	$348,835.50	67,600
12/12/2022	Jason P Rhodes	Director	Buy	934,581	$10.70	$10,000,016.70	934,581
12/12/2022	Richard William Scalzo	Insider	Sell	312	$10.87	$3,391.44	56,183
12/12/2022	Susanna High	COO	Sell	751	$10.87	$8,163.37	112,035
10/10/2022	Joshua T Brumm	Insider	Sell	195,800	$12.46	$2,439,668.00	204,623
10/7/2022	Joshua T Brumm	Insider	Sell	14,200	$13.37	$189,854.00	204,623
3/11/2022	Richard William Scalzo	Insider	Sell	308	$8.73	$2,688.84
3/11/2022	Susanna High	COO	Sell	765	$8.73	$6,678.45
3/2/2022	Wildon Farwell	Insider	Sell	5,617	$8.56	$48,081.52

Countdown to the biggest trade of my 25 yr career

From Timothy Sykes | Ad

Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… Breaking down the ONE MOVE you must make before the November 5th election to set yourself up for a prosperous 2025.

Click here to see the surprising reason why

SEC Filings (Institutional Ownership Changes) for Dyne Therapeutics (NASDAQ:DYN)

96.68% of Dyne Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Dyne Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/2/2024	Privium Fund Management B.V.	15,016	$0.54M	0.1%	+7.1%	0.015%
10/31/2024	Principal Financial Group Inc.	7,497	$0.27M	0.0%	-45.6%	0.007%
10/31/2024	Hanseatic Management Services Inc.	7,183	$0.26M	0.4%	N/A	0.007%
10/30/2024	AlphaCentric Advisors LLC	10,000	$0.36M	0.3%	-50.0%	0.011%
10/29/2024	Arcadia Investment Management Corp MI	38,614	$1.39M	0.2%	+9.8%	0.044%
10/28/2024	US Bancorp DE	1,368	$49K	0.0%	+776.9%	0.002%
10/25/2024	China Universal Asset Management Co. Ltd.	19,310	$0.69M	0.1%	+67.9%	0.022%
10/23/2024	Mirae Asset Global Investments Co. Ltd.	3,631	$0.12M	0.0%	+24.3%	0.004%
10/23/2024	Values First Advisors Inc.	1,720	$62K	0.0%	N/A	0.002%
10/21/2024	Genesee Capital Advisors LLC	15,400	$0.55M	0.3%	-5.9%	0.018%
10/11/2024	Creative Planning	10,605	$0.38M	0.0%	+41.5%	0.012%
10/5/2024	Handelsbanken Fonder AB	19,300	$0.69M	0.0%	+21.4%	0.022%
10/3/2024	SG Americas Securities LLC	18,344	$0.66M	0.0%	+198.9%	0.021%
8/19/2024	Point72 Asset Management L.P.	357,518	$12.62M	0.0%	-47.9%	0.409%
8/16/2024	Algert Global LLC	97,370	$3.44M	0.1%	+255.1%	0.111%
8/15/2024	The Manufacturers Life Insurance Company	126,244	$4.46M	0.0%	+96.2%	0.144%
8/15/2024	AQR Capital Management LLC	8,495	$0.30M	0.0%	+4.3%	0.010%
8/15/2024	Armistice Capital LLC	970,891	$34.26M	0.4%	-2.9%	1.111%
8/15/2024	AXA S.A.	210,149	$7.42M	0.0%	-24.6%	0.240%
8/15/2024	Affinity Asset Advisors LLC	100,000	$3.53M	0.4%	N/A	0.114%
8/14/2024	Squarepoint Ops LLC	45,196	$1.60M	0.0%	-42.9%	0.052%
8/14/2024	First Light Asset Management LLC	382,433	$13.50M	1.2%	+261.0%	0.438%
8/14/2024	Marshall Wace LLP	273,567	$9.65M	0.0%	+409.4%	0.313%
8/14/2024	Logos Global Management LP	265,000	$9.35M	0.8%	-84.7%	0.303%
8/14/2024	Farallon Capital Management LLC	6,000	$0.21M	0.0%	N/A	0.007%
8/14/2024	Integral Health Asset Management LLC	100,000	$3.53M	0.3%	N/A	0.114%
8/14/2024	Avoro Capital Advisors LLC	115,751	$4.09M	0.1%	N/A	0.132%
8/14/2024	ProShare Advisors LLC	15,170	$0.54M	0.0%	-7.0%	0.017%
8/14/2024	Profund Advisors LLC	27,421	$0.97M	0.0%	-48.7%	0.031%
8/13/2024	Ensign Peak Advisors Inc	312,752	$11.04M	0.0%	-48.8%	0.358%
8/13/2024	Sei Investments Co.	18,092	$0.64M	0.0%	-25.9%	0.021%
8/13/2024	Public Employees Retirement Association of Colorado	5,740	$0.20M	0.0%	N/A	0.007%
8/12/2024	Seven Eight Capital LP	53,739	$1.90M	0.2%	+195.7%	0.061%
8/12/2024	Amalgamated Bank	2,792	$99K	0.0%	+39.9%	0.003%
8/12/2024	E Fund Management Co. Ltd.	8,829	$0.31M	0.0%	-45.8%	0.010%
8/10/2024	Mutual of America Capital Management LLC	48,845	$1.72M	0.0%	N/A	0.056%
8/10/2024	Sofinnova Investments Inc.	1,625,703	$57.37M	3.0%	-16.1%	1.860%
8/9/2024	Renaissance Technologies LLC	126,000	$4.45M	0.0%	N/A	0.144%
8/9/2024	Dimensional Fund Advisors LP	171,185	$6.04M	0.0%	-47.6%	0.196%
8/8/2024	Federated Hermes Inc.	1,215,112	$42.88M	0.1%	+10.4%	1.391%
8/8/2024	American Century Companies Inc.	6,451	$0.23M	0.0%	N/A	0.007%
8/6/2024	Candriam S.C.A.	533,273	$18.82M	0.1%	-21.1%	0.610%
8/5/2024	Arcadia Investment Management Corp MI	35,175	$1.24M	0.2%	+12.3%	0.040%
8/5/2024	Arizona State Retirement System	15,070	$0.53M	0.0%	+26.9%	0.017%
8/5/2024	Victory Capital Management Inc.	19,152	$0.68M	0.0%	N/A	0.022%
8/3/2024	TD Asset Management Inc	152,210	$5.37M	0.0%	+103.5%	0.174%
8/1/2024	Rhumbline Advisers	121,595	$4.29M	0.0%	+23.7%	0.139%
8/1/2024	Privium Fund Management B.V.	14,016	$0.49M	0.1%	N/A	0.016%
8/1/2024	Lisanti Capital Growth LLC	106,140	$3.75M	0.9%	+22.5%	0.121%
7/29/2024	Principal Financial Group Inc.	13,771	$0.49M	0.0%	-10.6%	0.016%
7/26/2024	Legato Capital Management LLC	15,480	$0.55M	0.1%	+35.3%	0.018%
7/26/2024	Bank of New York Mellon Corp	311,504	$10.99M	0.0%	+52.5%	0.356%
7/20/2024	China Universal Asset Management Co. Ltd.	11,498	$0.41M	0.1%	-26.2%	0.013%
7/20/2024	Nisa Investment Advisors LLC	743	$26K	0.0%	+904.1%	0.001%
7/19/2024	Raymond James & Associates	100,750	$3.56M	0.0%	-40.4%	0.115%
7/19/2024	Genesee Capital Advisors LLC	16,359	$0.58M	0.3%	N/A	0.019%
7/12/2024	SG Americas Securities LLC	6,137	$0.22M	0.0%	N/A	0.007%
6/4/2024	DekaBank Deutsche Girozentrale	60,000	$1.71M	0.0%	+50.0%	0.069%
5/17/2024	RA Capital Management L.P.	4,954,779	$140.67M	1.8%	N/A	5.670%
5/17/2024	Artal Group S.A.	1,517,960	$43.10M	1.1%	+24.6%	1.737%
5/16/2024	California State Teachers Retirement System	44,784	$1.27M	0.0%	+29.9%	0.051%
5/16/2024	Janus Henderson Group PLC	2,675,240	$75.92M	0.0%	+23,512.0%	3.062%
5/15/2024	Baker BROS. Advisors LP	285,000	$8.09M	0.1%	N/A	0.326%
5/15/2024	First Light Asset Management LLC	105,948	$3.01M	0.2%	N/A	0.121%
5/15/2024	Price T Rowe Associates Inc. MD	1,132,092	$32.14M	0.0%	+8,284.6%	1.296%
5/14/2024	EntryPoint Capital LLC	7,552	$0.21M	0.2%	N/A	0.009%
5/14/2024	Natixis	14,000	$0.40M	0.0%	-65.0%	0.016%
5/14/2024	American International Group Inc.	29,138	$0.83M	0.0%	+31.8%	0.033%
5/13/2024	Seven Eight Capital LP	18,171	$0.52M	0.1%	N/A	0.021%
5/13/2024	Ameritas Investment Partners Inc.	5,896	$0.17M	0.0%	+28.0%	0.007%
5/10/2024	Vanguard Group Inc.	3,440,270	$97.67M	0.0%	+47.7%	3.937%
5/8/2024	ProShare Advisors LLC	16,307	$0.46M	0.0%	+44.6%	0.019%
5/8/2024	Russell Investments Group Ltd.	101,943	$2.89M	0.0%	+1.4%	0.117%
5/7/2024	Sei Investments Co.	24,410	$0.69M	0.0%	N/A	0.028%
5/7/2024	Concurrent Investment Advisors LLC	20,200	$0.57M	0.0%	N/A	0.023%
5/7/2024	Swiss National Bank	85,200	$2.42M	0.0%	+41.5%	0.098%
5/7/2024	Lisanti Capital Growth LLC	86,610	$2.46M	0.6%	N/A	0.099%
5/7/2024	Oppenheimer & Co. Inc.	28,529	$0.81M	0.0%	N/A	0.033%
5/6/2024	Atlas Venture Life Science Advisors LLC	8,020,136	$227.69M	21.0%	-18.9%	9.178%
5/2/2024	Jennison Associates LLC	1,207,551	$34.28M	0.0%	+495.2%	1.401%
5/1/2024	Capstone Investment Advisors LLC	20,248	$0.58M	0.0%	N/A	0.023%
5/1/2024	Mirae Asset Global Investments Co. Ltd.	28,617	$0.81M	0.0%	+24.9%	0.033%
4/30/2024	Allspring Global Investments Holdings LLC	1,210	$34K	0.0%	-47.8%	0.001%
4/29/2024	Principal Financial Group Inc.	15,403	$0.44M	0.0%	+5.9%	0.018%
4/29/2024	China Universal Asset Management Co. Ltd.	15,573	$0.44M	0.1%	+119.4%	0.018%
4/23/2024	Wetzel Investment Advisors Inc.	1,000	$28K	0.0%	N/A	0.001%
4/23/2024	Arcadia Investment Management Corp MI	31,325	$0.89M	0.2%	N/A	0.036%
4/22/2024	Vivo Capital LLC	1,635,136	$46.42M	3.6%	+58.0%	1.897%
4/22/2024	Raymond James & Associates	168,963	$4.80M	0.0%	+95.3%	0.196%
4/18/2024	Wasatch Advisors LP	417,794	$11.86M	0.1%	-75.2%	0.485%
4/18/2024	Allspring Global Investments Holdings LLC	1,210	$34K	0.0%	-47.8%	0.001%
4/12/2024	Vida Ventures Advisors LLC	407,499	$11.57M	6.4%	-80.4%	0.473%
3/7/2024	Fcpm Iii Services B.V.	6,131,079	$81.54M	24.2%	N/A	9.989%
3/5/2024	Wellington Management Group LLP	145,474	$1.94M	0.0%	+25.5%	0.237%
2/15/2024	Octagon Capital Advisors LP	792,945	$10.55M	1.7%	+14.4%	1.292%
2/15/2024	Frazier Life Sciences Management L.P.	1,184,840	$15.76M	0.8%	N/A	1.930%
2/14/2024	Commodore Capital LP	900,000	$11.97M	1.1%	N/A	1.466%
2/14/2024	Braidwell LP	755,811	$10.05M	0.4%	-58.5%	1.231%
2/14/2024	Wasatch Advisors LP	1,684,517	$22.40M	0.1%	-0.2%	2.744%
2/13/2024	Tower Research Capital LLC TRC	6,795	$90K	0.0%	-14.9%	0.011%

Data available starting January 2016

Dyne Therapeutics, Inc., a clinical-stage muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. Dyne Therapeutics, Inc. was incorporated in 2017 and is headquartered in Waltham, Massachusetts.

Today's Range

Now: $28.74

$27.66

$29.23

50 Day Range

MA: $34.65

$28.74

$46.09

52 Week Range

Now: $28.74

$7.09

$47.45

Volume

961,885 shs

Average Volume

1,504,002 shs

Market Capitalization

$2.89 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.05

Who are the company insiders with the largest holdings of Dyne Therapeutics?: Dyne Therapeutics' top insider shareholders include:
Jason P Rhodes (Director)
Venture Fund Xi LP Atlas (Major Shareholder)
Dirk Kersten (Director)
Joshua T Brumm (CEO)
Joshua T Brumm (Insider)
Susanna Gatti High (COO)
Oxana Beskrovnaya (Insider)
Wildon Farwell (Insider)
Jonathan Mcneill (Insider)
Richard William Scalzo (Insider)
Richard William Scalzo (SVP)
John Cox (CEO)
Learn More about top insider investors at Dyne Therapeutics.
Who are the major institutional investors of Dyne Therapeutics?: Dyne Therapeutics' top institutional investors include:
Arcadia Investment Management Corp MI — 0.04%
China Universal Asset Management Co. Ltd. — 0.02%
Handelsbanken Fonder AB — 0.02%
SG Americas Securities LLC — 0.02%
Genesee Capital Advisors LLC — 0.02%
Privium Fund Management B.V. — 0.01%
Learn More about top institutional investors of Dyne Therapeutics stock.
Which institutional investors are selling Dyne Therapeutics stock?: During the last quarter, DYN stock was sold by these institutional investors:
AlphaCentric Advisors LLC
Principal Financial Group Inc.
Genesee Capital Advisors LLC
Within the previous year, company insiders that have sold Dyne Therapeutics company stock include:
Jason P Rhodes (Director)
Venture Fund Xi LP Atlas (Major Shareholder)
Dirk Kersten (Director)
Joshua T Brumm (CEO)
Joshua T Brumm (Insider)
Susanna Gatti High (COO)
Oxana Beskrovnaya (Insider)
Wildon Farwell (Insider)
Jonathan Mcneill (Insider)
Richard William Scalzo (Insider)
Learn More investors selling Dyne Therapeutics stock.
Which institutional investors are buying Dyne Therapeutics stock?: During the last quarter, DYN stock was acquired by institutional investors including:
SG Americas Securities LLC
China Universal Asset Management Co. Ltd.
Hanseatic Management Services Inc.
Arcadia Investment Management Corp MI
Handelsbanken Fonder AB
Creative Planning
Values First Advisors Inc.
US Bancorp DE
During the last year, these company insiders have bought Dyne Therapeutics stock:
Jason P Rhodes (Director)
Venture Fund Xi LP Atlas (Major Shareholder)
Dirk Kersten (Director)
Learn More investors buying Dyne Therapeutics stock.